Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 560.00
Bid: 558.00
Ask: 560.00
Change: -2.00 (-0.36%)
Spread: 2.00 (0.358%)
Open: 548.00
High: 562.00
Low: 548.00
Prev. Close: 562.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

9 Jun 2009 07:00

RNS Number : 5644T
Gooch & Housego PLC
09 June 2009
 



For immediate release
9 June 2009

Gooch & Housego PLC

INTERIM REPORT FOR THE SIX MONTHS ENDED 31 MARCH 2009

Gooch & Housego PLC ('G&H' or 'Group'), the specialist manufacturer of optical components and systems, today announces its Interim Report for the six months ended 31 March 2009.

Financial highlights

Group revenue up 20.1% to £18.8m (2008: £15.7m) including contribution from acquisition

Revenue excluding acquisition and FX benefit down 18.2%

Adjusted EBITDA down 11.3% to £2.6m (2008 : £3.0m)

Adjusted Group operating profit down 33.3% to £1.6m (2008: £2.5m)

Statutory Group operating profit down 56.7% to £1.0m (2008: £2.2m)

Finance costs of £1.0relating to acquisition loan

Group profit before tax at breakeven (2008: £2.2m)

Adjusted basic EPS down 58.7% to 3.8p (2008: 9.2p) 

No interim dividend is proposed (2008: 1.5p)

Net assets of £29.595m, an increase of £0.555m from 30 September 2008.

Net debt increased to £17.390m relating to acquisition.

Good cash management performance. Net cash inflow of £1.223m for the period.

Operational highlights

Acquired California based ultra-precision optics manufacturer General Optics for US$21.6m

Challenging market conditions in the industrial laser market

Renegotiated banking facilities

Decisive action to reduce costs resulting in 16% reduction in headcount plus other savings

Order book of £20.4 million, up 26% since 30 September 2008

Global approach to new product development resulting in two new products launched

First sales of biomedical hyperspectral imaging system

Investment in developing new markets delivering exciting medium term opportunities 

For further information please contact:

Gooch & Housego PLC 

01460 256440

Gareth Jones / Andy Boteler / Paul Heal

07843 349 549

Buchanan Communications 

020 7466 5000

Tim Thompson / Chris McMahon

Investec Bank PLC

020 7597 4000

Patrick Robb / James Grace

  

Chairman's Statement 

The first half of our current financial year has continued to be challenging. On a like for like basis we have seen a decline in our revenues and profits when compared with the first half of last year despite the benefits of the strong dollar.

Trading conditions in our core industrial laser market continue to be subdued and our acousto -optic manufacturing facilities remain on a short time working pattern.

These difficult market conditions in our traditional markets have reinforced our strategy of product and market diversification. The acquisition in 2007 of our fibre optics division continues to add value with a significant contribution to Group revenues and the development of both evolutionary and revolutionary products. Research in nuclear power generation in both the US & Europe have given opportunities to our Cleveland facility. In our Instrumentation and Life Sciences business we have achieved our first commercial sales of our hyperspectral imaging systems. A range of new products continue to be developed and a number are now with potential customers on operational trials. This is tangible evidence that the investment in R&D expenditure in recent years will prove to be of benefit.

Our recent acquisition on the West Coast of America, which is now called Gooch & Housego (California) LLC, has given us entry into the US Defence and Aerospace markets. The financial performance of this business since acquisition has been challenging due to the depressed commercial airline market and the push back of orders from a major customer. However we have a high level of confidence that this facility will add a great deal to the Group in view of its world leading optics capability, which gives access to near term defence sector opportunities.

 

We are justifiably proud of our new production facility in Ilminster and were honoured by a visit by HRH The Duke of York KG who performed the formal opening ceremony. It was a memorable day for us all. This state of the art facility is giving us new customer opportunities from world class businesses. We are quoting for a number of contracts with potentially significant revenues for the manufacture of components and sub assemblies. 

Our exciting prospects are tempered by a degree of caution as we look at the immediate future. It is right that the management team are focussed on containing costs and maximising cash whilst world economic conditions are uncertain. However it is vital that this is not done in such a way as to prevent us taking full advantage of the prospects facing the Group. We now have the resources and facilities to take the Group forward into our chosen markets. We have an expanding product range and engineering and manufacturing capabilities that will secure growth for the medium term.

Dr Julian Blogh

Chairman

9 June 2009

  Chief Executive's Review

The first half of the 2009 financial year was characterised by the most difficult trading conditions we have experienced for many years. Despite this challenging economic environment we completed our largest acquisition to date and have we continued to implement our strategy of developing new products and markets.

In October we acquired General Optics, the global leader in ultra-precision optics based in MoorparkCalifornia. This acquisition gives us access to the important US aerospace and defence market, is highly complementary to our Ilminster, UK, operations and provides a platform to develop a large optics capability to meet the requirements of the laser nuclear fusion research sector.

The first quarter started in an air of nervousness and uncertainty with demand progressively softening across most product and market sectors. During the period we experienced a sudden and significant decrease in demand for our core Q-switch products for the industrial laser market, which in recent years has accounted for approximately 40% of revenues and a greater percentage of profitsAlthough no orders were cancelled, many customers either sharply reduced their monthly requirements or suspended shipments altogether.

With no immediate prospect of a recovery in demand we were forced to reduce our costs to bring them into line with our lower sales forecast. This regrettably included a number of redundancies in addition to other cost saving measures.

At the same time we were experiencing an unprecedented decline in the value of Sterling against the US Dollar, which had the effect of increasing the magnitude of our debt when converted into Sterling. As a result of the combination of a reduced profit forecast and the effect of the decline in the value of Sterling we found it necessary to renegotiate our borrowing facilities with the result that our bankers have provided a US$10 million, three year committed working capital facility in place of the previous one year facility.

As the second quarter progressed trading conditions stabilised. Demand for Q-switches recovered slightly following a period of de-stocking by our customers, but remained at a level considerably lower than at the start of the year. In general, those sectors of our business serving government funded research, defence and infrastructure projects continued to perform close to their original forecasts, while sectors linked to consumer spending, ranging from electronics to civil aviation, remained depressed and unpredictable. An order intake of £14.6 million in the quarter to 31 March 2009, much of which is scheduled for shipment this calendar year, is encouraging. A significant proportion of these orders are for products that Gooch & Housego was not making two years ago.

Despite the unfavourable economic conditions we have continued to invest in research & development but have focussed our efforts on fewer projects that have the potential to generate revenues in the near to medium term. We have been successful in obtaining funding for several collaborative research projects relevant to our target markets, and are collaborating with some highly relevant industrial and governmental partners.

Recent acquisitions and new product developments have given Gooch & Housego a broader customer and product base in new markets such as life sciences, aerospace & defence and telecommunications. Similarly, our investment in people, facilities and infrastructure has enabled Gooch & Housego to offer a much more comprehensive service to our customers. These initiatives have had the effect of mitigating some of the impact of the economic downturn and they are now beginning to generate some exciting new opportunities, some of which have the potential to make a meaningful contribution as early as 2010.

  

Divisional Trading Review

Optoelectronic Components and Materials

The industrial laser market has been badly affected by the economic downturn. Lasers are now widely used in industrial and electronic manufacturing, and many of these lasers use Q-switches. While the increasing use of lasers in manufacturing bodes well for the future, as the world's leading supplier of Q-switches Gooch & Housego has suffered significantly as a result of the global downturn in consumer spending and in general manufacturing. This has affected revenues and profitability at our Ilminster and Melbourne facilities. We see the beginnings of slight positive movement in this market as customer inventory levels are depleted and the world economy stabilises.

The Group's precision optics operations, based in Ilminster and Moorpark, whilst also suffering in the industrial and civil aviation sectors, have done well in both the defence and research markets, particularly as they continue to move up the value chain with subassemblies and modules rather that just components.

Our Torquay based fibre optics operation, with its diversified market base, has continued to do well and is expected to consolidate upon its good performance of last year.

Similarly, the supply of large crystals into the research market by our Cleveland based electro-optics and non-linear materials operation has exceeded expectations.

Instrumentation and Life Sciences

The commercial launch and initial sales of the hyperspectral imaging system represent a significant further step in leveraging our components expertise to develop higher value-add products. Alongside encouraging sales of another recently introduced system-level product aimed at microscopy and imaging applications, the Agile Light Source, we are gradually gaining presence in the important life sciences market.

Operational strategy and further integration

An increasing number of the opportunities we are now addressing require a combination of the capabilities and products from across the Group as a whole. In order to facilitate greater cross-fertilisation and respond more effectively we have begun to fully integrate our sales and R&D activities on a Group-wide basis. We will progressively dissolve the boundaries between the divisions and fully integrate the businesses, assimilating and maximising the contribution from Moorpark, eliminating duplication of manufacturing & products, and improving quality and delivery performance.

Responding to challenging market conditions

Given the weakness in the industrial laser market, it was appropriate that Gooch & Housego reviewed its cost base on a global basis. As a result we implemented Group-wide cost reduction programme which included redundancies, the cancellation of all bonus schemes, short time working in certain areas and salary sacrifices. Overall headcount has been reduced by 16% from the level at the start of the year. Annualised savings amount to approximately £3.4 million.

Whilst we believe that these steps were appropriate and necessary, it was essential that these cost reductions were achieved in a carefully planned manner in order that the Group's future capabilities were not jeopardised. In particular, we are confident that we will be able to respond to an upturn in demand for our core products and meet the requirements of the sizeable new opportunities that we are currently bidding on.

  Strategic overview

Over the last five years the Group has followed a strategy of developing new markets, broadening our range of products, capabilities and technologies and building a strong intellectual property portfolio. The acquisitions of a fibre optics business in 2007 and an aerospace and defence focussed precision optics business in 2008 are two examples of this. This strategy has established Gooch & Housego in a good defensive position in today's market place. Although the industrial laser market has suffered, the biomedical, research, high-reliability telecommunications and defence markets have remained resilient.

Going forward the defence and biomedical markets offer considerable potential in the near to medium term. The Group's broad offering of optical solutions, together with state of the art facilities and its heritage of innovation and quality, has positioned the company well with many of the key players in these market. 

In the longer term opportunities in nuclear fusion energy applications are hugely exciting, with Gooch & Housego being extremely well placed to contribute to what is expected to be a high profile and high value industry.

The global sales organisation is now fully in place, with additional sales offices in Denver, Colorado and Munich Germany. The Group is now seeing the benefits of a global and holistic approach to the projection of it products and capabilities to both new and existing customers.

Product strategy

Over the past few years we have established Gooch & Housego as a global technology business. An important part of our continued success is the investment in research & development, both organically and through acquisition. Whilst the Group does not anticipate any significant further acquisitions in the near term, investment in in-house R&D will be maintained broadly at current levels.

Our investment in research & development has been evident over the last six months with the launch of two new products at Photonics West, our industry's leading trade fair, in January 2009. The Fibre Q-Switch and Isolator are already generating interest and initial orders and reinforcing our position as the market leader in components for both solid-state and fibre lasers.

Gooch & Housego continues to follow a strategy of moving its products up the value chain. The Group is now successfully partnering with its customers to provide complete optical solutions that not only support the customer but also provide additional value to Gooch & Housego.

Prospects

Whilst we have reason to be cautiously optimistic about our medium to long term prospects, we do not expect to see a near term recovery in the industrial laser market, nor do we anticipate meaningful additional business from new products and initiatives before 2010. We therefore expect trading conditions to remain very challenging throughout the second half of the year. During that time we will continue to manage our costs and seek further efficiencies while ensuring that we are able to respond to opportunities as they arise.

Our employees

I would like to thank our employees for their support and understanding during a period which has been difficult for them as individuals. Our people have experienced redundancy, salary sacrifice and short time working. I give my commitment to them all that when better times return the Board are totally committed to resuming normal working and remuneration levels as soon as it is prudent to do so.

Gareth Jones

Chief Executive Officer

9 June 2009  Finance Director's Report 

Financial Performance - Income Statement

Group revenue for the six month period to 31 March 2009 amounted to £18.84m, an increase of £3.15m or 20.1% over the corresponding period last year. After taking account of the Gooch & Housego Moorpark acquisition and foreign exchange, group revenue was down 18.2% over the same period.

Adjusted earnings before interest, taxation, depreciation and amortisation (EBITDA) for the six month period to 31 March 2009, amounted to £2.65m (2008: £2.99m), a reduction of 11.3%.

Adjusted Group operating profit for the six month period to 31 March 2009 amounted to £1.64(2008: £2.46m). A reduction of 33.3%. 

The Group has incurred non recurring costs in the period amounting to £0.76m. These are in respect of redundancy and other costs associated with the cost reduction programme and the write off of finance costs following the Group's renegotiation of its banking facilities in March. There has also been a one off gain of £0.27m in respect of profit on the sale of part of the old Ilminster facility.

The acquisition of the Gooch & Housego Moorpark facility on the 7 October 2008 has contributed £3.27m in revenue and £0.15m in operating profit to the Group's results in the period to 31 March 2009. These results reflect lower than expected sales volumes due to delays in the placement of orders from a key customer. Intangible assets arising from the acquisition are being amortised over three years.

The Group continued its investment in Research & Development, with total expenditures incurred amounting to £1.84m (2008: £1.18m) representing 9.7% of revenue. Of this amount £0.29m (2008: £0.07m) has been capitalised in the period.

Sales & Marketing expenditure amounted to £1.32m (2008: £0.88m) representing 7.0% of revenue, due to the continued development of the Group's integrated world-wide sales force.

Adjusted basic earnings per share for the six months ended 31 March 2009 was 3.8p compared to 9.2p for the corresponding period last year.

Financial Performance - Balance Sheet

The Group Balance Sheet shows net assets of £29.60m, an increase of £0.56m on the year-end position as at 30 September 2008.

The biggest impact on the balance sheet in this period has been the acquisition of Gooch & Housego Moorpark. Intangible assets have increased to £19.88m (£7.44m as at 30 September 2008). This acquisition was funded through secured debt facilities and consequently total borrowings have increased by £14.56m since 30 September 2008 to £21.75m. Debt facilities were provided under three and a half year multi-currency loan agreements commencing 7 October 2008. In addition there is a three year US$10 million working capital facility.

Financial Performance - Cash

The Group net cash inflow in the six month period to 31 March 2009 totalled £1.22m, compared to a net outflow for the equivalent period last year of £4.07m. The Group has generated cash in spite of difficult trading conditions and increased interest payments. This has been achieved by focusing throughout the Group on the collection of receivables and the minimisation of inventories. This focus will continue.

Cash, cash equivalents and bank overdrafts as at 31 March 2009 amounted to a negative cash position of £2.26m, representing a movement of £0.26m from £2.00m as at 30 September 2008.

Net debt as at 31 March 2009 amounted to £17.39m (2008: £3.30m). The increase is primarily due to the funding provided by the Group's bankers for the acquisition of Gooch & Housego Moorpark, although this has also been impacted by fluctuations in foreign exchange and successful cash management.

Dividends

No interim dividend will be paid.

Paul Heal

Interim Finance Director

9 June 2009

 

Unaudited interim results for the 6 months ended 31 March 2009

Group Income Statement

Note

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Revenue

4

18,841

15,693

33,369

Cost of revenue

(11,559)

(8,041)

(17,479)

Gross profit

7,282

7,652

15,890

Research & Development

(1,548)

(1,110)

(2,703)

Sales & Marketing

(1,321)

(879)

(1,859)

Administration and other expenses

(4,206)

(3,696)

(6,350)

Other income

765

278

375

Operating profit

4

972

2,245

5,353

Net finance costs

(933)

(2)

(218)

Profit before income tax expense

39

2,243

5,135

Income tax expense

3

(13)

(647)

(1,558)

Profit for the period

26

1,596

3,577

Earnings per share - basic

5

0.1p

8.4p

18.5p

Reconciliation of operating profit to adjusted operating profit:

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Operating profit

972

2,245

5,353

Amortisation of acquired intangible assets

510

218

304

Restructuring and redundancy costs

425

-

-

Profit from sale of Cornhill shops

(265)

-

-

Adjusted operating profit

1,642

2,463

5,657

Reconciliation of net finance costs to adjusted net finance costs:

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Net finance costs

(933)

(2)

(218)

Costs associated with debt financing costs

330

-

-

Adjusted net finance costs

(603)

(2)

(218)

  Unaudited interim results for the 6 months ended 31 March 2009

Group Balance Sheet

Half Year to 31 Mar 2009 (Unaudited)

Half Year to31 Mar 2008(Unaudited)

Full Year to30 Sep 2008 (Audited)

£000

£000

£000

Non-current assets

Property, plant & equipment

17,744

15,965

16,376

Intangible assets

19,878

6,983

7,440

Deferred income tax assets

1,259

908

1,152

38,881

23,856

24,968

Current assets

Cash and cash equivalents

4,361

3,577

3,901

Trade and other receivables

7,468

5,791

7,470

Inventories

7,778

5,719

5,929

Income tax receivable

2,082

442

971

Non-current assets held for resale

345

21,689

15,874

18,271

Current liabilities

Borrowings

(8,472)

(7,111)

(6,720)

Trade and other payables

(5,075)

(3,584)

(4,961)

Income tax liabilities

(1,637)

(215)

(665)

Provision for other liabilities and charges

(252)

(236)

(264)

(15,436)

(11,146)

(12,610)

Net current assets

6,253

4,728

5,661

Non-current liabilities

Borrowings

(13,279)

(1,181)

(476)

Deferred income tax liabilities

(2,010)

(658)

(1,113)

Provision for other liabilities and charges

(250)

-

-

(15,539)

(1,839)

(1,589)

Net assets

29,595

26,745

29,040

Shareholders' equity

Capital and reserves  attributable to equity shareholders

Called up share capital

3,853

3,828

3,853

Share premium account

4,105

3,963

4,105

Merger reserve

2,671

2,671

2,671

Hedging Reserve

(240)

Cumulative translation reserve

823

(459)

62

Retained earnings

18,383

16,742

18,349

Equity Shareholders' Funds

29,595

26,745

29,040

   Unaudited interim results for the 6 months ended 31 March 2009

Group Statement of Changes 

in Equity

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Balance at beginning of period

29,040

25,995

25,995

Income tax movement on share options

-

(719)

(848)

Currency translation differences

761

108

629

Net income/(expense) recognised directly  in equity

761

(611)

(219)

Profit for the period

26

1,596

3,577

Total recognised income and expense

787

985

3,358

Employee share option schemes:

- Fair value of employee services

8

46

92

- Proceeds from shares issued

-

287

454

Dividends

-

(568)

(859)

Hedging reserve movement

(240)

(232)

(235)

(313)

Balance at end of the period

29,595

26,745

29,040

  Unaudited interim results for the 6 months ended 31 March 2009

Group Cash Flow Statement 

Note

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Cash flows from operating activities

Cash generated from operations

7

4,103

1,914

5,658

Income tax paid

(40)

(592)

(1,470)

Net cash generated from operating activities

4,063

1,322

4,188

Cash flows from investing activities

Acquisition of subsidiary, net of cash acquired

(12,335)

-

Purchase of property, plant and equipment

(374)

(4,648)

(4,594)

Sale of property, plant and equipment

285

-

Purchase of intangible assets

(389)

(79)

(421)

Interest received

29

47

94

Net cash generated from / (used in) financing activities

(12,784)

(4,680)

(4,921)

Cash flows from financing activities

Proceeds from borrowings

12,192

Proceeds from issue of ordinary shares

287

454

Repayment of borrowings

(1,798)

(173)

(261)

Interest paid

(450)

(262)

(554)

Dividends paid to ordinary shareholders 

(568)

(859)

Net cash used in financing activities

9,944

(716)

(1,220)

Net increase/(decrease) in cash, cash equivalents and bank overdraft

1,223

(4,074)

(1,953)

Cash, cash equivalents and bank overdraft at beginning of the period

(1,997)

513

513

Exchange (losses) / gains on cash and bank overdrafts

(1,485)

188

(557)

Cash, cash equivalents and bank overdrafts at the end of the period

(2,259)

(3,373)

(1,997)

 Cash, cash equivalents and bank overdrafts at the end of the period are made up of:

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Cash and cash equivalents

4,361

3,577

3,901

Bank overdraft

(6,620)

(6,950)

(5,898)

Cash, cash equivalents and bank overdrafts at the end of the period

(2,259)

(3,373)

(1,997)

  Notes to the Interim Report

 

1. Basis of Preparation

The unaudited Interim Report has been prepared under the historical cost convention and in accordance with International Financial Reporting Standards ("IFRS").

The Interim Report was approved by the Board of Directors and the Audit Committee on 5 June 2009. The Interim Report does not constitute statutory financial statements within the meaning of the Companies Act 1985 and has not been audited.

Comparative figures in the Interim Report for the year ended 30 September 2008 have been taken from the Group's audited statutory financial statements on which the Group's auditors, PricewaterhouseCoopers LLP, expressed an unqualified opinion. The comparative figures to 31 March 2008 are unaudited.

The Interim Report will be announced to all shareholders on the London Stock Exchange and published on the Group's website on 9 June 2008. Copies will be available to members of the public upon application to the Company Secretary at Dowlish Ford, Ilminster, SomersetTA19 0PF.

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 September 2008, as described in those financial statements.

2. Recent Accounting Developments

The following standards and amendments have been issued but application is not mandatory for the financial year ending September 2009. The Company's approach to their adoption is described below.

IAS 23 (amendment), "Borrowing costs", effective for annual periods commencing 1 January 2009 removes the discretion for the capitalisation of borrowing costs. No impact, as consistent with existing Company policy.

IFRS 2 (amendment) "Share-based payment", effective for annual periods commencing 1 January 2009.  Management is assessing the impact of changes to vesting conditions and cancellations.

IFRS 3 (amendment), "Business combinations", effective prospectively to business combinations where the acquisition date is on or after the beginning of the first annual reporting period commencing 1 July 2009.  Has no impact on the General Optics acquisition but may have an impact on future acquisitions. Management will assess the implications as and when there is a new acquisition.

 IAS 1 (amendment), "Presentation of financial statements", effective for annual periods commencing 1 January 2009.  Management is assessing the implications of adopting the new standard with a view to possible early adoption at the year ending 30 September 2009.

IFRS 8, "Operating segments", effective for annual periods commencing 1 January 2009.  This standard requires segment reporting to be presented on the same basis as that used for internal reporting purposes. Management is assessing the implications of adopting the new standard with a view to possible early adoption at the year ending 30 September 2009.

3. Income tax expense 

Income tax expense for the six months ended 31 March 2009 and 31 March 2008, respectively, has been estimated at prevailing rates.  Taxation for the year ended 30 September 2008 is the actual provision for the year.

  4. Segmental analysis

Half Year to 31 March 2009

Components 

& Materials

Instrumentation & Life Sciences

Corporate

Total

£000

£000

£000

£000

Revenue

Total Revenue

18,246

1,951

-

20,197

Inter and intra-division

(1,236)

(120)

-

(1,356)

External Revenue

17,010

1,831

-

18,841

Divisional expenses

(13,299)

(1,755)

(1,139)

(16,193)

Adjusted EBITDA¹

3,711

76

(1,139)

2,648

Adjusted EBITDA %

21.8%

4.2%

0.0%

14.1%

Restructuring and redundancy costs

(325)

-

(100)

(425)

Profit from sale of Cornhill shops

-

-

265

265

EBITDA¹

3,386

76

(974)

2,488

Depreciation and amortisation

(837)

(68)

(101)

(1,006)

Operating profit before amortisation of acquired intangible assets

2,549

8

(1,075)

1,482

Amortisation of acquired intangible assets 

(510)

-

-

(510)

Operating profit

2,039

8

(1,075)

972

Half Year to 31 March 2008

Components 

& Materials

Instrumentation & Life Sciences

Corporate

Total

£000

£000

£000

£000

Revenue

Total Revenue

15,694

1,699

-

17,393

Inter and intra-division

(1,628)

(72)

-

(1,700)

External Revenue

14,066

1,627

-

15,693

Divisional expenses

(10,164)

(1,546)

(998)

(12,708)

EBITDA¹

3,902

81

(998)

2,985

EBITDA %

24.9%

5.0%

0.0%

19.0%

Depreciation and amortisation

(348)

(26)

(148)

(522)

Operating profit before amortisation of acquired intangible assets

3,554

55

(1,146)

2,463

Amortisation of acquired intangible assets 

(218)

-

-

(218)

Operating profit

3,336

55

(1,146)

2,245

¹EBITDA = Earnings before interest, tax, depreciation and amortisation

All of the amounts recorded in this Interim Report are in respect of continuing operations.

 

5. Earnings per share

The calculation of earnings per 20p Ordinary Share is based on the profit for the period using as a divisor the weighted average number of Ordinary Shares in issue during the period. The weighted average number of shares is given below.

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Number of shares used for basic earnings per share

19,264,390

19,050,734

19,383,631

Dilutive shares

385,485

581,463

493,106

Number of shares used for dilutive earnings per share

19,650,075

19,632,197

19,876,737

A reconciliation of the earnings used in the earnings per share calculation is set out below:

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 30 Sep 2008(Audited)

£000

p per  share

£000

p per  share

£000

p per  share

Basic earnings per share

26

0.1p

1,596

8.4p

3,577

18.5p

Adjustments net of income tax expense:

Amortisation of acquired intangible assets

367

157

219

Restructuring and redundancy costs

306

-

-

Profit from sale of Cornhill shops

(191)

-

-

Costs associated with debt re-financing

237

-

-

Total adjustments net of income tax expense:

719

3.7p

157

0.8p

219

1.1p

Adjusted basic earnings per share

745

3.8p

1,753

9.2p

3,796

19.6p

Basic and diluted earnings per share before amortisation and adjustments has been shown because, in the opinion of the Directors, it more accurately reflects the trading performance of the Group.

The diluted earnings per share has not been shown as the difference between basic and diluted earnings per share is immaterial.

  6. Dividend

The Directors are proposing that no interim dividend is paid for the half year ending 31 March 2009.

Comparative dividend payments are shown below.

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Interim dividend paid: 1.5p per share (2006:1.4p)

-

-

291

No final dividend proposed nor paid for 2008. (2007: 3.0p)

-

568

568

-

568

859

7. Cash generated from operating activities

Half Year to 31 Mar 2009(Unaudited)

Half Year to 31 Mar 2008(Unaudited)

Full Year to 

30 Sep 2008(Audited)

£000

£000

£000

Profit before income tax

39

2,243

5,135

Adjustments for:

- Amortisation of acquired intangible assets

510

218

304

- Amortisation of other intangible assets

113

1

177

- Depreciation

893

521

971

- Profit/(loss) on disposal of property, plant 

and equipment

(265)

15

2

- Share option expense

(21)

46

(88)

- Finance income

(29)

(50)

(94)

- Finance costs

962

52

312

Total

2,163

803

1,584

Changes in working capital

- Inventories

(337)

(250)

(783)

- Trade and other receivables

2,678

956

(14)

- Trade and other payables

(444)

(1,838)

(387)

- Provisions for liabilities and charges

4

-

123

Total

1,901

(1,132)

(1,061)

Cash generated from operating activities

4,103

1,914

5,658

  8. Acquisition of General Optics

On 7 October 2008, the company acquired the trade and assets of General Optics from GSI Group for cash consideration of US$21.6 million. General Optics is located in MoorparkCalifornia and is the world leader in the manufacture of ultra-high quality optical components and coatings. 

The net tangible assets acquired per the net asset statement were US$6.1 million.  The cash consideration of US$21.6 million was funded by the Company's bankers through secured multi-currency debt facility. The table below sets out the net assets acquired:

Net Asset

Statement £000

Fair Value Adjustments £000

Fair Value £000

Property, plant and equipment

1,447

(81)

1,366

Intangible Assets

-

2,712

2,712

Cash

1

-

1

Trade and other receivables

1,415

(10)

1,405

Inventory

746

(232)

514

Trade and other payables 

(175)

(30)

(205)

Deferred tax

-

(997)

(997)

Net assets acquired

3,434

1,362

4,796

Consideration paid:

Cash

12,184

Costs of acquisition

275

Total consideration

12,459

Goodwill

7,663

9. Derivative financial instruments 

Half Year to 31 Mar 2009 (Unaudited)

Half Year to31 Mar 2008(Unaudited)

Full Year to30 Sep 2008 (Audited)

£000

£000

£000

Interest rate swap

334

-

-

Current portion

84

-

-

Non-current portion

250

-

-

334

-

-

The notional principal amount of the outstanding interest swap contract at 31 March 2009 was $12 million.

At 31 March 2009, the fixed rate of the interest rate swap was 3.19% and the floating rate was US dollar LIBOR. Gains and losses recognized on interest rate swap contracts in the hedging reserve will be released to the income statement as the borrowings are repaid.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ILFSRREITIIA
Date   Source Headline
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards
21st Dec 202210:02 amRNSPosting of Annual Report and Notice of AGM
20th Dec 202212:30 pmRNSDirector/PDMR Shareholding
6th Dec 20224:26 pmRNSDirector/PDMR Shareholding
6th Dec 20229:38 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSResults for the year ended 30 September 2022
25th Nov 20223:17 pmRNSHolding(s) in Company
23rd Nov 20224:27 pmRNSHolding(s) in Company
18th Nov 20222:20 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSNotification of Full Year Results
27th Oct 202212:56 pmRNSHolding(s) in Company
18th Oct 20222:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.